Yale Podnos's most recent trade in Oncology Institute Inc (The) was a trade of 17,974 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 14, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2026 | 17,974 | 0 | - | - | Stock Option (Right to Buy) | |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.43 per share. | 14 Jul 2026 | 17,974 | 259,527 | - | 6.4 | 115,555 | Common Stock |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.87 per share. | 14 Jul 2026 | 17,974 | 277,501 | - | 1.9 | 33,611 | Common Stock |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2026 | 5,478 | 0 | - | - | Stock Option (Right to Buy) | |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.35 per share. | 14 Jul 2026 | 5,478 | 259,527 | - | 6.3 | 34,785 | Common Stock |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. | 14 Jul 2026 | 5,478 | 265,005 | - | 2 | 10,956 | Common Stock |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 5.38 per share. | 08 Jun 2026 | 23,451 | 259,527 | - | 5.4 | 126,094 | Common Stock |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Other type of transaction at price $ 4.47 per share. | 21 May 2026 | 1,805 | 282,978 | - | 4.5 | 8,068 | Common Stock |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2026 | 66,446 | 300,956 | - | 0 | Common Stock | |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Other type of transaction at price $ 3.07 per share. | 27 Mar 2026 | 16,173 | 284,783 | - | 3.1 | 49,651 | Common Stock |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Other type of transaction at price $ 3.59 per share. | 17 Mar 2026 | 3,420 | 234,510 | - | 3.6 | 12,278 | Common Stock |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2025 | 2,086 | 237,930 | - | 0 | Common Stock | |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 1,202 | 235,844 | - | 0 | Common Stock | |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 306 | 234,642 | - | 0 | Common Stock | |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 2.68 per share. | 21 May 2025 | 1,801 | 234,336 | - | 2.7 | 4,818 | Common stock |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 157,088 | 236,137 | - | 0 | Common stock | |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.04 per share. | 26 Mar 2025 | 9,056 | 79,049 | - | 1.0 | 9,434 | Common Stock |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Mar 2025 | 4,528 | 4,528 | - | - | Common Warrant | |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.89 per share. | 19 Mar 2025 | 2,975 | 69,993 | - | 0.9 | 2,645 | Common stock |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.14 per share. | 20 Nov 2024 | 1,709 | 74,261 | - | 0.1 | 232 | Common stock |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.14 per share. | 20 Nov 2024 | 1,026 | 72,968 | - | 0.1 | 140 | Common stock |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.13 per share. | 20 Nov 2024 | 267 | 73,994 | - | 0.1 | 36 | Common stock |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Other type of transaction at price $ 0.00 per share. | 12 Nov 2024 | 17,039 | 75,970 | - | 0 | Common stock | |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Other type of transaction at price $ 0.00 per share. | 12 Nov 2024 | 11,359 | 93,009 | - | 0 | Common stock | |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 43,825 | 43,825 | - | - | Non-Qualified Stock Option (right to buy) | |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 17,530 | 104,368 | - | 0 | Common Stock | |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 2.19 per share. | 21 Nov 2023 | 1,530 | 86,838 | - | 2.2 | 3,355 | Common stock |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 2.38 per share. | 14 Nov 2023 | 1,860 | 88,368 | - | 2.4 | 4,436 | Common stock |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 2.39 per share. | 14 Nov 2023 | 238 | 90,228 | - | 2.4 | 568 | Common stock |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 83,047 | 83,047 | - | - | Non-Qualified Stock Option (right to buy) | |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 33,219 | 90,466 | - | 0 | Common stock | |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 71,895 | 71,895 | - | - | Non-Qualified Stock Option (right to buy) | |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 14,164 | 57,247 | - | 0 | Common Stock | |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.03 per share. | 15 Nov 2022 | 199 | 43,083 | - | 2.0 | 404 | Common Stock |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 64,567 | 64,567 | - | - | Stock Option (right to buy) | |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 10,984 | 10,984 | - | - | Stock Option (right to buy) | |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 77,916 | 77,916 | - | - | Stock Options (right to buy) | |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 68,208 | 68,208 | - | - | Stock Options (right to buy) | |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 17,039 | 17,039 | - | 0 | Common Stock | |
| Oncology Institute Inc | Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 11,359 | 11,359 | - | 0 | Common Stock |